Comparison of two platelet gylcoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Saved in:
| Title: | Comparison of two platelet gylcoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. |
|---|---|
| Authors: | Topol EJ (AUTHOR), Moliterno DJ (AUTHOR), Herrmann HC (AUTHOR), Powers ER (AUTHOR), Grines CL (AUTHOR), Cohen DJ (AUTHOR), Cohen EA (AUTHOR), Bertrand M (AUTHOR), Neumann F (AUTHOR), Stone GW (AUTHOR), DiBattiste PM (AUTHOR), Demopoulos L (AUTHOR), Do Tirofiban and ReoPro Give Similar Efficacy Trial Investigators (CORPORATE AUTHOR) |
| Source: | New England Journal of Medicine. 06/21/2001, Vol. 344 Issue 25, p1888-1894. 7p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
